Solanbridge Group Announces the addition of Grace White to Board of Solanbridge Nova Scotia
Solanbridge Group Announces the addition of Grace White to Board of Solanbridge Nova Scotia
White Heads CanJam Trading and will develop Jamaican Market
HOUSTON, TX / ACCESSWIRE / December 14, 2014 / Solanbridge Group Inc. (OTC: SLNX) is pleased to announce that it has added Ms. Grace White to the Advisory Board of Solanbridge Group NS, Inc. White will develop the Jamaican market for medical marijuana.
Earle G. Hickey, President of Solanbridge Group NS, Inc., stated, "We are very excited to welcome Ms. White to our team at SLNX. Not only will she bring a wealth of customer relationships from Eastern Canada, but she will also be bringing a book of clients from Jamaica. She has a quality sales team, and she knows the mechanics of both markets."
White established CanJam Trading Company from her Dartmouth home in 1989. Today, CanJam Trading is a successful international food trading house featuring over 35 products and exporting to every corner of the world. Sales to date are in excess of $30 million dollars.
Grace White is an active member of the Board of Directors of the Export Development Corporation, and a frequent speaker and presenter in the Saint Mary's University Executive Master of Business Administration (EMBA) program.
Grace has received honors which include an Honorary Doctorate of Commerce degree from St. Mary's University and the 1993 Rotman Canadian Woman Entrepreneur of the Year for International Competitiveness. Grace is a past director for Nova Scotia Business Inc. (NSBI), Export Development Corporation (EDC), Nova Scotia Business Development Corporation and the Royal Bank of Canada National Entrepreneur Advisory Council.
White grew up in Jamaica. She moved to Halifax, Nova Scotia where she attended Saint Mary's University in Halifax. Grace graduated with a Bachelor of Commerce degree. Following her graduation she started her career in the insurance industry.
About Solanbridge Group Inc.:
Solanbridge Group Inc, based in The Woodlands, Texas, is a diversified holding company looking to expand into the medical marijuana industry by developing commercial grower's licenses in Eastern Canadian medical marijuana jurisdictions, with the partnership of First Nations and developing CBD-infused products in Colorado and Nevada. Solanbridge is also pursuing other acquisitions in the growing medical marijuana field and partnerships with agribusiness entities.
This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. This presentation contains forward-looking statements that involve substantial risks and uncertainties. You can identify forward-looking statements by words such as anticipate, believe, could, estimate, expect, intend, may, plan, should, will, would or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. We believe that it is important to communicate our future expectations to our investors. There may be events in the future, however, that we are not able to predict accurately or control. Our actual results may differ materially from the expectations we describe in our forward looking statements. Factors or events that could cause our actual results to materially differ may emerge from time to time, and it is not possible for us to accurately predict all of them. Before you invest in our common stock, you should be aware that the occurrence of any such event could have a material adverse effect on our business, results of operation and financial position. Any forward-looking statement made by us in this presentation speaks only as of the date on which we make it. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Contact:
Charles R. Shirley
Solanbridge Group Inc.
charles@solanbridgegroup.com
832.225.1372
Source: Solanbridge Group Inc.
